SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹153 Cr | ₹133 Cr | ₹128 Cr | ₹95 Cr | ₹8,298,024 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹153 Cr |
| Mar2024 | ₹133 Cr |
| Mar2023 | ₹128 Cr |
| Mar2022 | ₹95 Cr |
| Mar2021 | ₹8,298,024 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹153 Cr | 14.99 | |
| Mar2024 | ₹133 Cr | 4.00 | |
| Mar2023 | ₹128 Cr | 35.35 | |
| Mar2022 | ₹95 Cr | -100.00 | |
| Mar2021 | ₹8,298,024 Cr | - | |
Compare Revenue of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹1,874.6 Cr | 5.3% | 4% | 130.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹480,047.0 Cr | 3.1% | 7.2% | 18.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹208,141.0 Cr | 8.2% | 19.8% | 17.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,264.0 Cr | -1.8% | 4.9% | 37.2% | Stock Analytics | |
| CIPLA | ₹118,430.0 Cr | 3.9% | 0.6% | 0% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,516.1 Cr | -0.7% | -14.6% | -8.4% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 5.3% |
4% |
130.4% |
| SENSEX | 2% |
1.9% |
-5.2% |
You may also like the below Video Courses